Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jessica Shepherd

Gynecology Dallas, TX Medical Doctor

NPI 1912160797 CMS profile 359009

5600 W Lovers Ln Ste 100, Dallas, TX 75209

Open in the dashboard

General payments

$809,377

800 records reported · program years 2019–2025

Research payments

$24,247

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jessica Shepherd of Dallas, TX is reported in the CMS Open Payments database as having received $809,377 across 800 general payments and $24,247 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,187 9
2024 General $93,443 90
2023 General $107,925 88
2023 Research $10,497 5
2022 General $73,682 73
2021 General $146,197 124
2020 General $148,092 82
2020 Research $13,750 4
2019 General $216,851 334

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jessica Shepherd
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Jessica Shepherd were reported at $23,187. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Jessica Shepherd Gynecology median Middle half National median
2019 $216,851 $199 $66–$472 $163
2020 $148,092 $114 $42–$287 $114
2021 $146,197 $141 $42–$430 $132
2022 $73,682 $173 $52–$532 $149
2023 $107,925 $170 $57–$501 $160
2024 $93,443 $157 $50–$424 $164
2025 $23,187 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $371,055 417 payments
  2. Astellas Pharma US Inc $153,715 142 payments
  3. Gen-Probe, Inc. $54,071 18 payments
  4. CooperSurgical, Inc. $52,745 10 payments
  5. Acessa Health Inc. $36,600 46 payments
  6. Pfizer Inc. $32,956 27 payments
  7. Acessa Health Inc. $28,304 45 payments
  8. Exeltis, USA Inc. $22,900 3 payments
  9. Myovant Sciences Inc. $15,615 24 payments
  10. Hologic Inc $13,251 6 payments
  11. Other $28,166 62 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $422,996 173 payments
  2. Consulting Fee $270,494 65 payments
  3. Travel and Lodging $96,396 292 payments
  4. Food and Beverage $13,290 268 payments
  5. Honoraria $6,200 2 payments
Products named General payments · program years 2019–2025
  1. Orilissa Endocrinology $160,674 224 payments
  2. ORIAHNN $126,585 110 payments
  3. Veozah $124,197 132 payments
  4. ORILISSA Womens Health $89,532 82 payments
  5. Paragard $52,584 6 payments
  6. Acessa $28,304 45 payments
  7. NONE $26,300 8 payments
  8. ACESSA PROVU SYSTEM Surgical $21,656 32 payments
  9. ACESSA PROVU SYSTEM Surgical $16,333 23 payments
  10. MYFEMBREE $15,615 24 payments
  11. Other $77,626 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $13,750 4 payments
  2. Astellas Pharma Global Development $10,497 5 payments

Records

809 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record